Mario Gabelli Reveales Latest Moves In Its Equity Portfolio
Mario Gabelli's fund GAMCO Investors and its affiliates, have revealed in several filings with the SEC, some of the latest moves related to the holdings in its equity portfolio...
Posts Tagged ‘NASDAQ:CADX’
Cadence Pharmaceuticals, Inc. (CADX), Griffin Land & Nurseries, Inc. (GRIF) and Three Other Moves From Mario Gabelli and GAMCO Investors
As usual, Mario Gabelli has been very active this week. His fund, GAMCO Investors, has reported two new positions and has increased its investment in three other companies.
Should You Buy Optimer Pharmaceuticals, Inc. (OPTR)?
At the moment, there are plenty of metrics investors can use to track their holdings. Two of the most under-the-radar are hedge fund and insider trading interest.
Hedge Funds Are Dumping EXACT Sciences Corporation (EXAS)
In the financial world, there are a multitude of gauges shareholders can use to analyze Mr. Market. Two of the most innovative are hedge fund and insider trading interest.
Hedge Funds Are Buying ACADIA Pharmaceuticals Inc. (ACAD)
In the eyes of many of your fellow readers, hedge funds are viewed as overrated, outdated financial tools of a forgotten age.
Array Biopharma Inc (ARRY): Hedge Funds Are Bearish and Insiders Are Undecided, What Should You Do?
At the moment, there are many methods investors can use to analyze Mr. Market. Some of the most innovative are hedge fund and insider trading sentiment.
Halozyme Therapeutics, Inc. (HALO), Viropharma Inc (VPHM): Three Horrendous Health-Care Stocks This Week
One decision led to a double whammy this week for biotech companies Halozyme Therapeutics, Inc. (NASDAQ:HALO) and Viropharma Inc (NASDAQ:VPHM).
Is Merrimack Pharmaceuticals Inc (MACK) Going to Burn These Hedge Funds?
According to most shareholders, hedge funds are seen as slow, old financial vehicles of the past.
Hedge Funds Are Dumping Optimer Pharmaceuticals, Inc. (OPTR)
Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) was in 11 hedge funds' portfolio at the end of March. OPTR investors should be aware of a decrease in hedge fund interest lately.
Here is What Hedge Funds Think About ACADIA Pharmaceuticals Inc. (ACAD)
To most market participants, hedge funds are viewed as underperforming, outdated financial vehicles of the past.
Should You Avoid ACADIA Pharmaceuticals Inc. (ACAD)?
To most traders, hedge funds are seen as unimportant, outdated investment tools of the past.
Should You Avoid Merrimack Pharmaceuticals Inc (MACK)?
To the average investor, there are a multitude of gauges investors can use to monitor their holdings.
ACADIA Pharmaceuticals Inc. (ACAD): Insiders Are Dumping, Should You?
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) was in 12 hedge funds' portfolio at the end of the fourth quarter of 2012.
